Secondary menu

Agila Specialties Recalls Etomidate Injection

Mylan Inc. subsidiary Agila Specialties has initiated nationwide recall of Etomidate injection manufactured at pharmaceutical facility in Warsaw, Poland. The company first informed about the recall on February 13.

The injections have possibility of containing small black particles. The intravenous administration of Etomidate could lead to infection, embolism or phlebitis. The injections are used for the induction of general anesthesia. The injections were marketed by Pfizer.

The company has recalled 10 lots of vials with 10ml and 20ml capacity. The lot numbers include, 5001012, 5000927, 5000931, 5000936, 5000942, 5001071 for 20ml and 5001040, 5001023, 5000983 and 5000986 for 10 ml dosage.

Mylan customer care can be contacted at 800.848.0462 for clarification on the recall. Both the companies have not reported any incidents so far.